Application Of CRISPR-Cas in Pathogen Detection

Authors

  • Yunfei Wu

DOI:

https://doi.org/10.54097/hset.v45i.7383

Keywords:

CRISPR-Cas, Pathogen Detection, Infectious Disease.

Abstract

Infectious diseases have had a significant influence on the market economy and human civilization in recent years. Traditional nucleic acid tests typically include a lot of procedures, are complicated, take a long time to complete, and have significant space, staff, and equipment needs. More and more study is being done in this area as a result of the identification of clustered regularly interspaced short palindromic repeats and related(CRISPR-Cas) proteins in prokaryotes. The CRISPR-Cas system has been extensively used to detect viruses that cause infectious diseases due of its high specificity and sensibility. The history of the CRISPR-Cas system, including its revised categorization, is discussed in this paper. Besides, a summary of the use of various CRISPR-Cas system types in pathogen detection is also provided in the paper, along with an introduction to the CRISPR-Cas system’s basic principles employing CRISPR-Cas9 as an example. As a biosciences frontier hot spot, research on CRISPR-Cas systems is developing quickly and technology based on the CRISPR-Cas system for detecting pathogens is extremely useful in clinical diagnosis and biological research.

Downloads

Download data is not yet available.

References

Li JW, Wang YX, Wang B, Lou J, Ni P, Jin YF, Chen SY, Duan GC, Zhang RG. Application of CRISPR-Cas systems in the Nucleic Acid Detection of Infectious Diseases [J]. Diagnostics, 2022, 12(10): 2455.

Gao HD, Shang ZF, Siew YC, Ma DL. Recent advances in the use of the CRISPR-Cas system for the detection of infectious pathogens [J]. Journal of Zhejiang University-SCIENCE B, 2022, 23(11):881-899.

Ishino Y, Shinagawa H, Makino K, et al. Nucleotide sequence of the iap gene, responsible for alkaline phosphataseisozyme conversion in Escherichia coli, and identification of the gene product [J]. Journal of Bacteriology, 1987, 168(12):5429-5433.

Mojica FJ, Diez-Villasenor C Soria E, et al. biological significance of a family of regularly spaced repeats in the genomes of archaea, bacteria and mitochondria [J] Mol Micro-biol, 2000, 36(1):244-246.

Jansen R, Embden JD, Gaastra W, et al. Identification of a novel family of sequence repeats among prokaryotes [J]. OMICS, 2002, 6(1):23-33.

Mojica FJ, Diez-Villasensor C, Garcia-Martinez J, Soria E. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements [J]. J Mol Evol, 2005, 60:174-182.

Gasiunas G, Barrangou R, Horvath P, Siksnys V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage foradaptive immunity in bacteria [J]. Proc Natl Acad Sci U S A, 2012, 109:E2579-2586.

Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna, JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity [J]. Science, 2012, 337:816-821.

Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo, JE. RNA-guided human genome engineering via Cas9 [J]. Science, 2013. 339(6121): 823-826.

Makarova KS, Wolf YI, Alkhnbashi OS, et al. Anupdated evolutionary classification of CRISPR-Cas systems [J]. Nat Rev Microbiol, 2015, 13(11):722-736.

Beloglazova N, Petit P, Flick R, et al. Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference [J]. EMBO J, 2011, 30:4616-4627.

Xiao Y, Luo M, Dolan AE, et al. Structure basis for RNA-guided DNA deg-radation by Cascade and Cas3 [J]. Science, 2018, 361.

Westra ER, van Erp PB, Kunne T, et al. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3 [J]. Mol cell, 2012, 46:595-605.

Jung TY, A Y, Park KH, et al. Crystal structure of the Csm1 subunit of the Csm complex and its single-stranded DNA-specific nuclease activity [J]. Structure, 2015, 23:782-790

Zhang J, Graham S, Tello A, et al. Mutiple nucleic acid cleavage modes in divergent type Ⅲ CRISPR systems [J]. Nucleic Acids Res, 2016, 44:1789-1799.

Liu TY, Lavarone AT, Doudna JA. RNA and DNA targeting by a reconstituted Thermus thermophilus type Ⅲ-A CRISPR-Cas system [J]. PLoS One, 2017, 12:e0170552.

Feng WY, Meng LN, Chen C, He LZ, Qin GS, Shi DS. Research progress in CRISPR-Cas system classification and pathogen detection [J]. Biotechnology, 2022, 32(02):258-267.

Marsic T, Ali Z, Tehseen M, Mahas A, Hamdan S, Mahfouz M. Vigilant: An Engineered VirD2-Cas9 Complex for Lateral Flow Assay-Based Detection of SARS-CoV2-2 [J]. Nano Lett, 2021, 21:3596-3603.

East-Seletsky A, O’Connell MR, Knight SC, et al. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection [J]. Nature, 2016, 538(7624):270-263.

Gootenberg JS, Abudayyeh OO, Lee JW, et al. Nucleic acid detection with CRISPR-Cas13a/C2c2 [J]. Science, 2017, 356(6336):438-442.

Gootenberg JS, Abudayyeh OO, Kellner MJ, et al. multi-plexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6 [J]. Science, 2018, 360(6387):439-444.

Qin PW, Park M, Alfson KJ, et al. Rapid and fully microfluidic ebola virus detection with CRISPR-Cas13a [J]. ACS Sens, 2019, 4(4):1048-1054.

Ackerman CM, Myhrvold C, Thakku SG, Freije CA, Metsky HC, Yang DK, Ye SH, Boehm SK, Kosoko-Thoroddsen TF, Kehe J, et al. Massively mutiplexed nucleic acid detection with Cas13 [J]. Nature, 2020, 582:277-282.

Li H, Dong X, Wang Y, Yang L, Cai L, Zhang X, Kou Z, He L, Sun S, Li T, et al. Sensitive and Easy-Read CRISPR Strip for COVID-19 Rapid Point-of-Care Testing. The CRISPR Journal, 2021, 4(3): 392-399.

Gao HD, Shang ZF, Zeng YY, Ma DL. Research progress of CRISPR-Cas system for detection of infectious disease pathogens [J]. Journal of Zhejiang University-Science B, 2022, 23(11):881-899.

Ackerman C, Myhrvold C, Boehm C, et al. Programmable inhibition and detection of RNA viruses using Cas13 [J]. Molecule Cell, 2019, 76(5):826-837.

Li SY, Cheng QX, Wang JM, et al. CRISPR-Cas12a-assisted nucleic acid detection [J]. Cell Discovery, 2018, 4(1):1255-1266.

Joung J, Ladha A, Satio M, et al. Detection of SARS-CoV-2 with SHERLOCK one-pot testing [J]. N Engl J Med, 2020, 383(15):1492-1494.

Downloads

Published

18-04-2023

How to Cite

Wu, Y. (2023). Application Of CRISPR-Cas in Pathogen Detection. Highlights in Science, Engineering and Technology, 45, 239-244. https://doi.org/10.54097/hset.v45i.7383